Abcellera Biologics shares owned by Citigroup
Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Abcellera Biologics
Tip: Access up to 7 years of quarterly data
All positions including Abcellera Biologics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Abcellera Biologics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $30k | 8.5k | 3.49 |
| 2025-03-31 | $9.7k | 4.3k | 2.23 |
| 2024-12-31 | $38k | 13k | 3.00 |
| 2024-09-30 | $13k | 5.2k | 2.50 |
| 2024-06-30 | $238k | 79k | 3.00 |
| 2024-03-31 | $18k | 4.0k | 4.50 |
| 2023-12-31 | $46k | 8.1k | 5.69 |
| 2023-09-30 | $20k | 4.3k | 4.58 |
| 2023-03-31 | $39k | 5.1k | 7.54 |
| 2022-12-31 | $78k | 7.7k | 10.13 |
| 2022-09-30 | $68k | 10k | 6.76 |
| 2021-12-31 | $5.5M | 383k | 14.26 |
| 2021-03-31 | $7.0k | 200 | 35.00 |